He says it's been an incredibly active period for them where, among a number of developments, they've confirmed that Nuvec® works for both DNA and mRNA delivery.
N4 Pharma's Nuvec platform 'on a clear path' towards clinical trials
Quick facts: N4 Pharma PLC
Price: 3.25 GBX
Market Cap: £3.3 m
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...FOR OUR FULL DISCLAIMER CLICK HERE